TERT and metabolic dysfunction-associated steatotic liver disease: Akuta et al. identified the TERT C228T mutation in 63.9% of NAFLD-HCC patients through cfDNA analysis, even with normal alpha-fetoprotein and des-carboxyprothrombin levels [105].